Skip to Main Content

Author Details

Yves Fradet
CHU de Quebec-Universite Laval
1975
333
68
PMIDPaper TitleJournal TitlePublished Year
37931285Salvage therapy for BCG failure with intravesical sequential gemcitabine and docetaxel in patients with recurrent NMIBC.Can Urol Assoc J2024
36343786UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.Cancer Lett2023
37787025Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trial.Cancer Med2023
37190147Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.Cancers (Basel)2023
37086156Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.Mol Oncol2023
36986098Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA).Nutrients2023
37435060High infiltration of CD209<sup>+</sup> dendritic cells and CD163<sup>+</sup> macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.Front Immunol2023
36494006Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.Ann Oncol2023
34259197Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer.Asian J Androl2022
35598879Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion.Mol Metab2022
35528461Sex steroid modulation of macrophages within the prostate tumor microenvironment.Am J Clin Exp Urol2022
35621285Perception and satisfaction of patients after telemedicine urology consultations: A matched analysis with physicians' perspective.Can Urol Assoc J2022
36246841Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment.Eur Urol Open Sci2022
36272848Analysis of sex-based differences to Bacillus Calmette-Guérin for non-muscle invasive bladder cancer.Urol Oncol2022
35075795Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype.Clin Transl Med2022
35247908Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.Clin Cancer Res2022
35063205Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy.Clin Nutr ESPEN2022
35031549A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota.Cancer Discov2022
32676741Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.World J Urol2021
33750523<sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy.Can Urol Assoc J2021
34944863Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.Cancers (Basel)2021
34575920Identification of Abundant and Functional dodecaRNAs (doRNAs) Derived from Ribosomal RNA.Int J Mol Sci2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
34051178Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.Lancet Oncol2021
33276284Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth.Prostaglandins Leukot Essent Fatty Acids2021
33262291Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity.Mol Cancer Res2021
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
31899651Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.J Urol2020
32047296Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.Br J Cancer2020
33275556Building a Canadian Translational Bladder Cancer Research Network.Can Urol Assoc J2020
33275552A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemedicine.Can Urol Assoc J2020
33299664Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.Oncoimmunology2020
33324443Identification of a Transcriptomic Prognostic Signature by Machine Learning Using a Combination of Small Cohorts of Prostate Cancer.Front Genet2020
32971005Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.Lancet Oncol2020
29609897Increased Prostate Cancer Glucose Metabolism Detected by <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Castration.Eur Urol Focus2019
30073695Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated mice.Prostate2019
31594737Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?Clin Genitourin Cancer2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
31475741Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.Prostate2019
31018850Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.Radiat Oncol2019
31156708Large-Scale Automatic Feature Selection for Biomarker Discovery in High-Dimensional OMICs Data.Front Genet2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
30733309A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer.Cancer Epidemiol Biomarkers Prev2019
30763236Canadian Urological Association guideline: Muscle-invasive bladder cancer.Can Urol Assoc J2019
31050707Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of &gt;2 years of follow-up.Ann Oncol2019
30871997Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series.Urol Oncol2019
30673630Discordance between testosterone measurement methods in castrated prostate cancer patients.Endocr Connect2019
28972698Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.BJU Int2018
30021911Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 Trial.Clin Cancer Res2018
29880461Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer.Urol Oncol2018
  • 1 - 50 of 333

Recommended Authors

Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 15
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 24
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 6
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 17
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 23
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 4
Syed A Hussain
University of Sheffield and Sheffield Teaching Hospitals
Career Start Year 2001
Number of shared co-authors 15
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 2
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 23
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 23
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 27
Alan Thompson
The Royal Marsden NHS Foundation Trust
Career Start Year 1996
Number of shared co-authors 6
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 4
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 23
Chris Ogden
The Royal Marsden Hospital NHS Foundation Trust
Career Start Year 1993
Number of shared co-authors 6
Penny Flohr
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 17
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 10
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 16
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 15
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 7
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 41
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 26
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 16
Jolanta Bondaruk
The University of Texas MD Anderson Cancer Center
Career Start Year 1985
Number of shared co-authors 6
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 55
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 23
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 37
Cathy Corbishley
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 6
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 33

Collaborators

Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers 99
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 44
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 40
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 30
Fred Saad
University of Montreal Health Center
Co-authored papers 29
Joseph L Chin
University of Western Ontario
Co-authored papers 26
Fran??ois Meyer
Laval University
Co-authored papers 24
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 19
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers 19
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 15
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 12
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 12
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 11
Isabelle Bairati
Laval University Cancer Research Center
Co-authored papers 10
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 10
Neil E Fleshner
University of Toronto
Co-authored papers 8
Paul C Boutros
University of California los angeles
Co-authored papers 8
Herv?? Brisson
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 7
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Co-authored papers 7
David Robert Siemens
Queen's University
Co-authored papers 7
Robert G Bristow
University of Toronto
Co-authored papers 7
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Douglas S Scherr
New York-Presbyterian Hospital
Co-authored papers 7
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers 6
Arnaud Droit
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Co-authored papers 6
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 6
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Co-authored papers 5
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 5
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Co-authored papers 5
Ronald de Wit
Erasmus MC Cancer Institute
Co-authored papers 5
Release 1.2